Sonova launches AI products: Goldman target for Sonova stock is CHF 315
Published on 10/15/2026 at 12:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSProduct rollout and financial scale
- Sonova presented Roger On Sphere and Integro at EUHA on October 14, 2026.
- Fiscal 2025/26 sales reached CHF 3,605.9 million, up 5.9 percent in local currencies.
- Sonova stock trades at EUR 291.45 at 12:46 p.m. CEST at Lang & Schwarz on October 15, 2026.
Sonova stock was trading at EUR 291.45 at Lang & Schwarz on October 15, 2026, at 12:46 p.m. CEST. On October 14, 2026, Sonova presented new artificial intelligence products at the EUHA congress, while Goldman Sachs set a CHF 315.00 target in a separate October 8, 2026 note.
EQS News reported that Sonova is extending real-time AI beyond hearing aids with the Roger On Sphere remote microphone and Advanced Bionics Integro cochlear implant processors. Roger On Sphere is scheduled for availability from mid-November 2026, while Integro has received TÜV approval for selected European markets.
AI products broaden the platform
The product announcement gives Sonova two routes to extend its technology stack. Roger On Sphere separates speech from background noise in real time, and Integro adds sound localization, AI processing and connectivity for cochlear implant users. The release states that compatible systems can connect with up to eight devices, a concrete feature that supports Sonova's broader cross-platform strategy.
What does the launch mean?
The financial backdrop gives the rollout a measurable benchmark. In fiscal year 2025/26, sales reached CHF 3,605.9 million, up 5.9 percent in local currencies, while normalized EBITA rose 17.3 percent to CHF 811.2 million, according to Sonova. The company also guided for fiscal 2026/27 sales growth of 5 percent to 8 percent and core EBIT growth of 7 percent to 10 percent at constant exchange rates.
Three dated milestones
On May 18, 2026, Sonova reported fiscal 2025/26 sales of CHF 3,605.9 million. On October 8, 2026, Investing.com reported that Goldman Sachs upgraded Sonova to Buy and raised its target from CHF 230.00 to CHF 315.00. On October 14, 2026, Sonova presented Roger On Sphere and Integro, with Roger On Sphere planned for mid-November 2026.
Upcoming reporting dates
The next dated milestones are November 12, 2026, when Sonova is scheduled to report results, and mid-November 2026, when Roger On Sphere is scheduled to become available, according to Investing.com and EQS News.
Price holds near the yearly high
The Swiss primary-market quote was CHF 271.20 on October 15, 2026, at 12:36 p.m. CEST, with a 52-week range of CHF 163.00 to CHF 273.20 and a market capitalization of CHF 16.1 billion. Sonova's latest product cycle therefore arrives while the share price remains close to its yearly high, leaving the November report as the next test of whether product momentum is translating into financial performance.
Sonova stock was trading at EUR 291.45 at Lang & Schwarz on October 15, 2026, at 12:46 p.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Sonova stock.
Sonova stock key data
- Company: Sonova Holding AG
- ISIN: CH0012549785
- Ticker: SOON
- Primary exchange: SIX Swiss Exchange
- Price Lang & Schwarz (as of October 15, 2026, 12:46 p.m. CEST): EUR 291.45
- Market capitalization: CHF 16.1 billion (as of October 15, 2026)
- 52-week range: CHF 163.00-273.20 (as of October 15, 2026)
- Sector / Industry: Healthcare / Medical Devices
Market context: Market report SMI.
